Progress in the Medicinal Chemistry of Group III Metabotropic Glutamate Receptors

Annual Reports in Medicinal Chemistry

Volumn 46, Issue , 2011, Pages 3-17

  Liu, Kevin G ^a   Doller, Darío ^a  

^a LUNDBECK RESEARCH USA   (United States)

Author keywords

Agonist; Allosteric; Antagonist; Lu AF21934; MGlu; Modulator; PHCCC

Indexed keywords

EID: 80054112015     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386009-5.00026-6     Document Type: Chapter

References (72)

1. Attwood T.K., Findlay J.B.C. Protein Eng. 1994, 7:195.
2. Nicoletti F., Bockaert J., Collingridge Graham L., Conn P.J., Ferraguti F., Schoepp D.D., Wroblewski J.T., Pin J.P. Neuropharmacology 2011, 60:1017.
3. Niswender C.M., Conn P.J. Annu. Rev. Pharmacol. 2010, 50:295.
4. O'Neill M.J., Fell M.J., Svensson K.A., Witkin J.M., Mitchell S.N. Drugs Future 2010, 35:307.
5. Hopkins C.R., Lindsley C.W., Niswender C.M. Future Med. Chem. 2009, 1:501.
6. O'Connor R.M., Finger B.C., Flor P.J., Cryan J.F. Eur. J. Pharmacol. 2010, 639:123.
7. Schoepp D.D., Jane D.E., Monn J.A. Neuropharmacology 1999, 38:1431.
8. Lavreysen H., Dautzenberg F.M. Curr. Med. Chem. 2008, 15:671.
9. Recasens M., Guiramand J., Aimar R., Abdulkarim A., Barbanel G. Curr. Drug Targets 2007, 8:651.
10. Selvam C., Goudet C., Oueslati N., Pin J.-P., Acher F.C. J. Med. Chem. 2007, 50:4656.
11. Acher F.C., Tellier F.J., Azerad R., Brabet I.N., Fagni L., Pin J.-P.R. J. Med. Chem. 1997, 40:3119.
12. Sibille P., Lopez S., Brabet I., Valenti O., Oueslati N., Gaven F., Goudet C., Bertrand H.-O., Neyton J., Marino M.J., Amalric M., Pin J.-P., Acher F.C. J. Med. Chem. 2007, 50:3585.
13. Johnson R.L., Rao K.S.S.P. Bioorg. Med. Chem. Lett. 2005, 15:57.
14. Selvam C., Oueslati N., Lemasson I.A., Brabet I., Rigault D., Courtiol T., Cesarini S., Triballeau N., Bertrand H.-O., Goudet C., Pin J.-P., Acher F.C. J. Med. Chem. 2010, 53:279.
15. Acher F., Selvam C., Triballeau N., Pin J.-P., Bertrand H.-O. Preparation of hypophosphorous acid derivatives, particularly substituted hypophosphorous acid-containing glycine derivatives, as agonists and antagonists of metabotropic glutamate receptors, especially mGluR4 2007, Patent WO 2007052169, 2007.
16. Triballeau N., Acher F., Brabet I., Pin J.-P., Bertrand H.-O. J. Med. Chem. 2005, 48(7):2534.
17. Beurrier C., Lopez S., Revy D., Selvam C., Goudet C., Lherondel M., Gubellini P., Kerkerian-LeGoff L., Acher F., Pin J.-P., Amalric M. FASEB J. 2009, 23:3619.
18. Kemp M., Roberts P., Pook P., Jane D., Jones A., Jones P., Sunter D., Udvarhelyi P., Watkins J. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 1994, 266:187.
19. Jane D.E., Pittaway K., Sunter D.C., Thomas N.K., Watkins J.C. Neuropharmacology 1995, 34:851.
20. Jane D.E., Thomas N.K., Tse H.W., Watkins J.C. Neuropharmacology 1996, 35:1029.
21. Miller J.C., Howson P.A., Conway S.J., Williams R.V., Clark B.P., Jane D.E. Br. J. Pharmacol. 2003, 139:1523.
22. Jane D.E., Jones P.L.S.J., Pook P.C.K., Tse H.W., Watkins J.C. Br. J. Pharmacol. 1994, 112:809.
23. Kemp M.C., Jane D.E., Tse H.-W., Roberts P.J. Eur. J. Pharmacol. 1996, 309:79.
24. Thomas N.K., Jane D.E., Tse H.W., Watkins J.C. Neuropharmacology 1996, 35:637.
25. Kingston A.E., Ornstein P.L., Wright R.A., Johnson B.G., Mayne N.G., Burnett J.P., Belagaje R., Wu S., Schoepp D.D. Neuropharmacology 1998, 37:1.
26. Fitzjohn S.M., Bortolotto Z.A., Palmer M.J., Doherty A.J., Ornstein P.L., Schoepp D.D., Kingston A.E., Lodge D., Collingridge G.L. Neuropharmacology 1998, 37:1445.
27. Rocheville M., Garland S.L. Drug Discovery Today Technol. 2010, 7:E87.
28. Marino M.J., Williams D.L., O'Brien J.A., Valenti O., McDonald T.P., Clements M.K., Wang R., DiLella A.G., Hess J.F., Kinney G.G., Conn P.J. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13668.
29. Maj M., Bruno V., Dragic Z., Yamamoto R., Battaglia G., Inderbitzin W., Stoehr N., Stein T., Gasparini F., Vranesic I., Kuhn R., Nicoletti F., Flor P.J. Neuropharmacology 2003, 45:895.
30. Annoura H., Fukunaga A., Uesugi M., Tatsuoka T., Horikawa Y. Bioorg. Med. Chem. Lett. 1996, 6:763.
31. Canudas A.M., Di Giorgi-Gerevini V., Iacovelli L., Nano G., D'Onofrio M., Arcella A., Giangaspero F., Busceti C., Ricci-Vitiani L., Battaglia G., Nicoletti F., Melchiorri D. J. Neurosci. 2004, 24:10343.
32. Battaglia G., Busceti C.L., Molinaro G., Biagioni F., Traficante A., Nicoletti F., Bruno V. J. Neurosci. 2006, 26:7222.
33. Choe E.S., Shin E.H., Wang J.Q. Neurosci. Lett. 2006, 394:246.
34. Stachowicz K., Klak K., Klodzinska A., Chojnacka-Wojcik E., Pilc A. Eur. J. Pharmacol. 2004, 498:153.
35. Stachowicz K., Chojnacka-Wojcik E., Klak K., Pilc A. Pharmacol. Rep. 2006, 58:820.
36. Klak K., Palucha A., Branski P., Sowa M., Pilc A. Amino Acids 2007, 32:169.
37. Iacovelli L., Arcella A., Battaglia G., Pazzaglia S., Aronica E., Spinsanti P., Caruso A., De Smaele E., Saran A., Gulino A., D'Onofrio M., Giangaspero F., Nicoletti F. J. Neurosci. 2006, 26:8388.
38. Williams R., Zhou Y., Niswender C.M., Luo Q., Conn P.J., Lindsley C.W., Hopkins C.R. ACS Chem. Neurosci. 2010, 1:411.
39. Niswender C.M., Johnson K.A., Weaver C.D., Jones C.K., Xiang Z., Luo Q., Rodriguez A.L., Marlo J.E., de Paulis T., Thompson A.D., Days E.L., Nalywajko T., Austin C.A., Williams M.B., Ayala J.E., Williams R., Lindsley C.W., Conn P.J. Mol. Pharmacol. 2008, 74:1345.
40. Christov C., Gonzalez-Bulnes P., Malhaire F., Karabencheva T., Goudet C., Pin J.-P., Llebaria A., Giraldo J. ChemMedChem 2011, 6:131.
41. Williams R., Johnson K.A., Gentry P.R., Niswender C.M., Weaver C.D., Conn P.J., Lindsley C.W., Hopkins C.R. Bioorg. Med. Chem. Lett. 2009, 19:4967.
42. Doller D., Uberti M.A., Hong S.-P., Nerio M.T., Brodbeck R.M., Breysse N., Merciadez M.A., Vialeti T., DenBlekyer M., Fallon S., Bacolod M.A., Nattini M.E., Cajina M., Liu K.G., Topiol S.W., Sabio M., Andersson D., Sager T.N., Fog K. Lu AF21934, a brain penetrant mGlu4 receptor positive allosteric modulator tool compound. 655.28/M10 2010.
43. Niswender C.M., Lebois E.P., Luo Q., Kim K., Muchalski H., Yin H., Conn P.J., Lindsley C.W. Bioorg. Med. Chem. Lett. 2008, 18:5626.
44. Williams R., Niswender C.M., Luo Q., Le U., Conn P.J., Lindsley C.W. Bioorg. Med. Chem. Lett. 2009, 19:962.
45. Engers D.W., Gentry P.R., Williams R., Bolinger J.D., Weaver C.D., Menon U.N., Conn P.J., Lindsley C.W., Niswender C.M., Hopkins C.R. Bioorg. Med. Chem. Lett. 2010, 20:5175.
46. Engers D.W., Niswender C.M., Weaver C.D., Jadhav S., Menon U.N., Zamorano R., Conn P.J., Lindsley C.W., Hopkins C.R. J. Med. Chem. 2009, 52:4115.
47. Engers D.W., Field J.R., Le U., Zhou Y., Bolinger J.D., Zamorano R., Blobaum A.L., Jones C.K., Jadhav S., Weaver C.D., Conn P.J., Lindsley C.W., Niswender C.M., Hopkins C.R. J. Med. Chem. 2011, 54:1106.
48. Cheung Y.-Y., Zamorano R., Blobaum A.L., Weaver C.D., Conn P.J., Lindsley C.W., Niswender C.M., Hopkins C.R. ACS Comb. Sci. 2011, 13:159.
49. McCauley J.A., Butcher J.W., Hess J.W., Liverton N.J., Romano J.J. Sulfonamide derivatives as mGluR4 receptor ligands 2010, Patent WO 2010033350, 2010.
50. McCauley J.A., Hess J.W., Liverton N.J., McIntyre C.J., Romano J.J., Rudd M.T. Preparation of phthalimidephenylpyridinecarboxamide derivatives for use as metabotropic glutamate R4 modulators 2010, Patent WO 2010033349, 2010.
51. Hess J., Clements M.J., McDonald T.P., Liverton N., McCauley J.A., Butcher J.W., Nguyen K., Charvin D., Campo B., Bolea C., Le Poul E., Reynolds I.J. Identification and characterization of radioligands that bind to an allosteric modulator site on the mGlur4 receptor. 643.22/F23 2010.
52. Mathiesen J.M., Svendsen N., Brauner-Osborne H., Thomsen C., Ramirez M.T. Br. J. Pharmacol. 2003, 138:1026.
53. East S.P., Bamford S., Dietz M.G.A., Eickmeier C., Flegg A., Ferger B., Gemkow M.J., Heilker R., Hengerer B., Kotey A., Loke P., Schaenzle G., Schubert H.-D., Scott J., Whittaker M., Williams M., Zawadzki P., Gerlach K. Bioorg. Med. Chem. Lett. 2010, 20:4901.
54. Bolea C., Celanire S. Preparation of novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors 2009, Patent WO 2009010455, 2009.
55. Hong S.-P., Liu K.G., Ma G., Sabio M., Peterson J., Uberti M.A., Bacolod M.D., Zou Z.Z., Robichaud A.J., Doller D. J. Med. Chem. 2011, 54:5070.
56. Braeuner-Osborne H., Slok F.A., Skjaerbaek N., Ebert B., Sekiyama N., Nakanishi S., Krogsgaard-Larsen P. J. Med. Chem. 1996, 39:3188.
57. Ahmadian H., Nielsen B., Braeuner-Osborne H., Johansen T.N., Stensbol T.B., Slok F.A., Sekiyama N., Nakanishi S., Krogsgaard-Larsen P., Madsen U. J. Med. Chem. 1997, 40:3700.
58. Mitsukawa K., Yamamoto R., Ofner S., Nozulak J., Pescott O., Lukic S., Stoehr N., Mombereau C., Kuhn R., McAllister K.H., van der Putten H., Cryan J.F., Flor P.J. Proc. Natl. Acad. Sci. USA 2005, 102:18712.
59. Ayala J.E., Niswender C.M., Luo Q., Banko J.L., Conn P.J. Neuropharmacology 2008, 54:804.
60. Niswender C.M., Johnson K.A., Miller N.R., Ayala J.E., Luo Q., Williams R., Saleh S., Orton D., Weaver C.D., Conn P.J. Mol. Pharmacol. 2010, 77:459.
61. Brodbeck R.M., Scotty F., Pu X., Uberti M., Issac L.K., Schulenburg T., Chen B., Didriksen M. 159.23/T12. Characterization of AMN082: A rich pharmacology which does not appear to include a measurable stimulation of the mGlu7 receptor 2010.
62. Sukoff Rizzo S., Leonard S.K., Gilbert A., Dollings P., Smith D.L., Zhang M.-Y., Di L., Platt B.J., Neal S., Bender C., Zhang J., Lock T., Kowal D., Kramer A., Randall A., Sears S., Huselton C., Vishwanathan K., Butera J., Ring R.H., Rosenzweig-Lipson S., Hughes Z.A., Dunlop J. 643.28/F29. The mGluR7 allosteric agonist AMN082 is a monoaminergic agent in disguise! 2010.
63. Suzuki G., Tsukamoto N., Fushiki H., Kawagishi A., Nakamura M., Kurihara H., Mitsuya M., Ohkubo M., Ohta H. J. Pharmacol. Exp. Ther. 2007, 323:147.
64. Nakamura M., Kurihara H., Suzuki G., Mitsuya M., Ohkubo M., Ohta H. Bioorg. Med. Chem. Lett. 2010, 20:726.
65. Thomas N.K., Clayton P., Jane D.E. Eur. J. Pharmacol. 1997, 338:111.
66. Thomas N.K., Wright R.A., Howson P.A., Kingston A.E., Schoepp D.D., Jane D.E. Neuropharmacology 2001, 40:311.
67. Linden A.-M., Bergeron M., Baez M., Schoepp D.D. Neuropharmacology 2003, 45:473.
68. Folbergrova J., Druga R., Haugvicova R., Mares P., Otahal J. Neuropharmacology 2008, 54:665.
69. Marabese I., Rossi F., Palazzo E., de Novellis V., Starowicz K., Cristino L., Vita D., Gatta L., Guida F., Di Marzo V., Rossi F., Maione S. J. Neurophysiol. 2007, 98:43.
70. Jiang F.L., Tang Y.C., Chia S.C., Jay T.M., Tang F.R. Epilepsia 2007, 48:783.
71. Stachowicz K., Klak K., Pilc A., Chojnacka-Wojcik E. Pharmacol. Rep. 2005, 57:856.
72. Marabese I., de Novellis V., Palazzo E., Scafuro M.A., Vita D., Rossi F., Maione S. Neuropharmacology 2007, 52:253.